Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Sell
48
SRPT Quote, Financials, Valuation and Earnings
Last price:
$74.08
Seasonality move
:
14.66%
Day range:
$73.05 - $75.50
52-week range:
$73.05 - $173.25
Dividend yield:
0%
P/E ratio:
32.50x
P/S ratio:
4.35x
P/B ratio:
4.71x
Volume:
2.6M
Avg. volume:
1.7M
1-year change:
-40.69%
Market cap:
$7.2B
Revenue:
$1.9B
EPS (TTM):
$2.28
SRPT Analysts' Consensus Rating
The 15 analysts providing 12-month price projections for Sarepta Therapeutics shares anticipate an average target of $172.01, ranging from a low estimate of $75.00 to a high estimate of $215.00. This average target implies a growth of 132.13% compared to the current stock price of $74.10.
Consensus Price Target
$172.01
Highest Price Target
$215.00
Lowest Price Target
$75.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 9 | 12 | 12 |
| Hold | 1 | 1 | 2 |
| Sell | 0 | 1 | 1 |
| Consensus | Buy | Buy | Buy |
SRPT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
